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Abstract 
Purpose: To investigate the formation of atorvastatin calcium (AC) co-crystal to improve its solubility 
and dissolution rate. 
Method: Co-crystallization of AC in equimolar ratio with isonicotinamide (INA) was carried out by slow 
solvent evaporation method using methanol. The solid obtained was characterized by powder x-ray 
diffraction (PXRD), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy 
(FTIR), scanning electron microscopy (SEM), and then further evaluated for solubility and dissolution. 
Results: The PXRD pattern of ACINA showed new crystalline peaks at 2θ values of 8.2 and 18.3o, 
indicating the presence of a new crystalline phase of ACINA co-crystal. The DSC thermogram of ACINA 
displayed a melting point at 201.7 oC which is higher than the melting points of AC (159.4 oC) and INA 
(158.0 oC). The FTIR spectra of AC in ACINA shifted the absorption peak from 3363 to 3280 cm-1 and to 
1216 to 1222 cm-1. The absorption peak shift is presumably due to N-H and C-N groups of AC form the 
hydrogen bonding interaction with groups in INA molecule. The solubility of ACINA co-crystal in distilled 
water was 270.7 mg/L which is significantly higher (p < 0.05) than that of pure AC (140.9 mg/L). The 
dissolution rate of ACINA co-crystal was 2 - 3 times faster than that of pure AC.  
Conclusion: AC and INA in equimolar ratio forms a co-crystal by slow solvent evaporation. ACINA co-
crystal significantly increases in solubility with a dissolution rate 2 - 3 times faster than that of pure AC. 
The enhancement of aqueous solubility and dissolution rate of AC with co-crystallization may be a 
potential way to solving the bioavailability problem of AC.  
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Atorvastatin calcium (AC), ([(R-(R*,R*)]-2-(4-
fluorophenyl)-beta, delta-dihydroxy-5-(1-
methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-
1H-pyrrole-1-heptanoic acid), which is calcium 
salt (2:1) trihydrate ([C33H34FN2O5]2Ca.3H2O), is 
considered one of the most effective synthetic 
lipid lowering agents 1,2. The drug is 
administered orally to reduce total cholesterol, 
low density lipoprotein and triglycerides 3. AC 
has very good intestinal permeability but it has 
poor aqueous solubility 4. This is caused oral 
by the bioavailability of AC of only about 12 - 14 
% 1,5. Thus, enhancement of aqueous 
solubility of AC may be a potential way to solving 
the bioavailability problem of AC 3. 
 
Co-crystallization is one of the techniques 
generally implemented by researchers to fix the 
physicochemical properties of an active 
pharmaceutical ingredient (API) 6-8. Co-crystal 
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is defined as a non-single component system 
consisting of various components that are 
completely solid under ambient conditions and 
attached with non-covalent bonds such as 
hydrogen bonds, aromatic-aromatic interactions 
and van der Waals bonds 6,9,10. 
 
A pharmaceutical co-crystal normally consists of 
two types: API and an API with appropriate co-
former. The most frequently used co-formers to 
form pharmaceutical co-crystal are carboxylic 
acids and amides 11. Co-crystallization of API 
is the most frequently selected technique to 
optimize physiochemical properties while 
retaining its molecular structure. The 
physiochemical properties apparently proven to 
be fixed through co-crystallization are solubility, 
dissolution rate, moisture uptake, stability, and 
bioavailability 12. 
 
The most common methods for production of co-
crystals are solution crystallization, mechanical 
grinding and melt crystallization. However, there 
are other techniques such as fast evaporation, 
super-critical fluids, addition of anti-solvent, 
sonic-slurring, melt-extrusion, wet compression, 
dry compression 9,13. Co-crystallization by 
evaporation of stoichiometric solutions is the 
general technique to prepare of co-crystal 11.  
 
The main objective of the present work was to 
investigate the formation of AC co-crystal in 
order to enhance the solubility and dissolution 






AC was a gift from PT Dexa Medica (Indonesia). 
INA and methanol were obtained from Sigma-
Aldrich (France) and Smart Lab (Indonesia), 
respectively.  
 
Co-crystallization of ACINA 
 
Co-crystallization was achieved by the slow 
solvent evaporation method. AC and INA in 
equimolar ratio (1:1) were placed into the glass 
beaker then added methanol and stirred with a 
magnetic stirrer until dissolved. The glass beaker 
was covered with aluminum foil and given the 
small holes. The solution in glass beaker was 
allowed at room temperature for slowly 
evaporation of the solvent. The solid of ACINA 
was obtained then crushed and characterized by 
PXRD, DSC, FTIR, SEM and further examined 
by solubility and dissolution test. 
Characterization of co-crystal 
 
Powder x-ray diffraction  
 
Philip Xpert diffractometer with Cu Kα radiation 
(1.54060 Å) is used for difractogram X-ray check 
of sample. The divergence slit and anti-scattering 
slit condition was set at 0.25° with diffraction 
experiment on the 10-mm sample size. The 
measurement was carried out 5-50° in 2θ with a 
step size of 0.017° and a step time of 10 s/step. 
 
Differential scanning calorimetry  
 
Rigaku Thermo Plus EVO II was used in the 
analysis of DSC samples. Sealed aluminium 
pans were used as the container of 
approximately 2 mg sample and the 
measurement was applied at 50 -250 C with 10 
C/min heating rate. The dry nitrogen 
atmosphere was conducted in the experiments.  
 
Fourier transform-infrared spectroscopy 
 
ALPHA Bruker spectrometer was applied for the 
measurement of FTIR spectra of samples. The 
FTIR spectra of samples were taken using a 
spectra resolution of 4 cm-1 in the wavenumber 
range of 4000-600 cm-1.  
 
Scanning electron microscopy  
 
Prior to the experiment, samples were coated 
with platinum using ion sputter coater Hitachi E-
1045 for 10 seconds. The SEM of samples was 
then examined using TM 3000 (Hitachi Tabletop 
Microscope) with observation condition modes 





The solubility of AC co-crystal and pure AC in 
distilled water were determined by shake-flask 
method. An excess of each sample was placed 
in Erlenmeyer flask and water added. The 
resulting suspension was moved into orbital 
incubator (Stuart S1600) at 37 ± 0.5 C and 
continuously shaken at 150 rpm for 12 h. Sample 
was then filtered using membrane filter (cellulose 
nitrate 0.45 μm pore size) and the filtrate 
absorption was measured by double beam 
spectrophotometer (Hitachi U-2900). The 
solubility experiments were repeatedly carried 




The sample powder was sieved with a size 80 
mesh sieve so that the sample powder was 
Wicaksono et al 
Trop J Pharm Res, July 2017; 16(7): 1499  
 
produced with a similar particle size distribution. 
Dissolution tests were conducted using USP 
apparatus with a stirring speed of 150 rpm and a 
temperature of 37 ± 0.5 °C. The test was carried 
out with a distilled water dissolution medium of 
900 mL and a sample amount of 25 mg 
equivalent of AC. Sampling was carried out at 
15, 30, 45, 60, 90 and 120 min and replacement 
of new media with the same amount after each 
sampling. The sample was filtered with a 
cellulose nitrate membrane filter of 0.45 μm and 
then filtrate concentration was measured using 
UV-Vis spectrophotometer (Hitachi U-2900). 




The statistical analysis was conducted using one 
way analysis of variance (ANOVA) of SPSS 
version 16.0 for windows. The differences of 
average values were considered to be significant 




Powder x-ray diffractograms 
 
PXRD was used to detect formation of co-crystal. 
The PXRD patterns of AC, INA and ACINA are 
displayed in Figure 1. PXRD pattern of AC 
presenting specific diffraction peaks at 2θ values 
of 10.0, 11.6, 19.3 and 21.4, while INA had 
specific diffraction peaks at 2θ values of 17.6, 
20.7, 23.3 and 25.7. ACINA had displayed 
crystalline peaks of PXRD pattern at 2θ values of 




Figure 2 shows DSC curves of AC, INA and 
ACINA. AC has two endothermic peaks that is 
one peak at 108.5C and the other is at 159.4C, 
whereas INA has one sharp endothermic peak at 
158.0C. DSC curve of ACINA showed different 
endothermic peak with AC and INA, which was 
observed at 201.7C. 
 
Fourier transform infrared spectra 
 
The FTIR spectra of AC, INA, and ACINA are 
illustrated in Figure 3. AC has characteristic 
spectra with a sharp absorption peak at 3373 
cm-1 indicating O-H stretching (free), aromatic N-
H stretching at 3363 cm-1, C=O stretching at 
1649 cm-1 and C-N stretching at 1216 cm-1. FTIR 
spectra of INA showed N-H stretching at 3368 
and 3184 cm−1, C=O stretching of carboxylic acid 
at 1658 cm−1, NH2 stretching at 1623 cm−1, C-N 
stretching at 1394 cm−1 and O-C-N stretching at 
630 cm−1. The FTIR spectra of ACINA has 
characteristic absorption peaks at 3280, 1648, 

















Figure 4 shows SEM images of AC, INA and 
ACINA. The shape of AC particle has acicular 
with size of length approximately about 30-100 
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µm, while INA has angular-shaped particles with 
a size of approximately 100 µm. The shape of 












The solubility of ACINA and pure AC were 
determined in distilled water. The solubility of 
pure AC and ACINA in distilled water are 140.9 
mg/L and 270.7 mg/L, respectively. Result 
founded that the solubility of AC from ACINA was 




The dissolution profiles of ACINA and pure AC 
are presented in Figure 5. ACINA reached AC 
dissolution 74 % within 15 min. However, only 
24% of pure AC was dissolved during the same 
period. After 120 min, about 92% of AC was 
dissolved from ACINA, while only 50% of pure 




Each  crystalline  substance   has  unique  and  
 
 
Figure 5: Dissolution profiles of (a) AC and (b) 
ACINA 
 
specific PXRD pattern. It is the fingerprint of the 
crystalline materials indicating the reflections of 
specific atomic planes 14,15. PXRD pattern of 
ACINA was different from those of the individual 
pattern of AC and INA. These new PXRD 
patterns of ACINA indicate the presence of a 
new crystalline phase of ACINA 16,17. 
 
In the research of physicochemical properties of 
drugs, thermal properties play a pivotal role as it 
is an indicator of other drug properties. DSC 
measurement is one method of thermal 
properties check used to detect the formation of 
co-crystal [13. In the DSC thermogram, the 
formation of co-crystal is characterized by a 
single endothermic peak different from other 
initial components. The new endothermic peak 
indicates the melting point of the co-crystal 
phase [18. 
 
DSC curves of AC showed abroad peak at 108.5 
C which depict water loss, followed by a second 
endothermic peak due to water loss and melting 
at 159.4 C 1. The DSC curve of INA has one 
endothermic peak at 158.0 C due to the melting 
point of INA. The ACINA has a sharp 
endothermic peak at 201.7 C, indicating the 
fusion of ACINA. Based on the DSC curve of 
ACINA it turns out that AC and INA have a lower 
melting point than ACINA's co-crystal melting 
point. 
 
FTIR spectroscopy is one of the commonly used 
methods to identify co-crystal conformation. With 
the analysis of FTIR spectra the conformation 
structure among the functional groups of the 
constituent components of the co-crystal can be 
estimated. The interaction between functional 
groups in the co-crystal will result in a shift in the 
peaks of FTIR spectra absorption compared to 
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its individual component [11. The interaction of 
functional groups on the co-crystal through 
hydrogen bonds of the amide-acid group will shift 
the frequency of absorption of both OH and NH 
groups towards the individual component 
absorption frequency. The hydrogen bond 
usually causes a red shift in the co-crystal as the 
hydrogen bond apparently stronger in the co-
crystal than each of the constituents [19]. 
 
The shifting of peaks was observed in FTIR 
spectra of ACINA. The FTIR spectra of AC in 
ACINA shift in N-H stretching frequency from 
3363 to 3280 cm−1 and C-N stretching from 1216 
to 1222 cm−1. Absorption peaks of C=O 
stretching of AC at 1650 cm−1 did not shift but 
decreased in sharpness. The shifting of 
absorption peaks of AC in ACINA can 
correspond to hydrogen bond of the N-H and C-
N group of AC with group of INA. The 
appearance of new FTIR spectra of ACINA is 
due to the occurrence of co-crystal formation via 
intermolecular interaction between AC and INA 
20,21. Overall, from the results of PXRD 
pattern DSC curve and FTIR spectra, the sample 
of ACINA may be concluded as a co-crystal. 
 
Co-crystal physical properties are strongly 
influenced by the shape and size. SEM is a 
reliable method to analyze the morphology and 
particle size of the co-crystal 11,22. The SEM 
analysis revealed that morphology of ACINA is 
different from the individual components. 
 
AC has poorly water-soluble and highly 
permeable properties including a drug class II in 
biopharmaceutics classification system [3. 
Modify of AC into ACINA co-crystal can 
significantly (p<0.05) increase the solubility of AC 
in distilled water. Co-crystal has the ability to 
increase solubility of drug possibly due to 
changing of crystal packing which reduces the 
lattice energy and/or increase the solvent affinity 
9. 
 
The dissolution test results indicate that ACINA 
co-crystal dissolves faster than the pure AC. The 
result has indicated that AC in ACINA co-crystal 
exhibited a dissolution rate 2-3 times faster than 
that of pure AC. The enhancement of dissolution 
rate of ACINA co-crystal can be explained by 
effects of changing crystal morphology of AC into 
ACINA co-crystal. The difference of ACINA co-
crystal surface forms a new surface nature of the 
crystal. Thus, it changes the dissolution stage of 
the co-crystal. Overall, the increased dissolution 
rate of ACINA co-crystal appears as a 
combination of crystal packing and morphology 




AC and INA in equimolar ratio are capable of 
forming a co-crystal by slow solvent evaporation 
method. ACINA co-crystal has a spherical shape 
with a rough surface. Modification of AC into 
ACINA co-crystal increases the solubility and 
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